Sign in to continue:

Wednesday, July 29th, 2026

Future Vision II Acquisition Corp. Shareholders Approve Name Change to MicroTouch Inc. Following Business Combination




Future Vision II Acquisition Corp. – Shareholder Meeting Results and Business Combination Approval

Future Vision II Acquisition Corp. (Nasdaq: FVNNU, FVN, FVNNR) Announces Shareholder Approval of Business Combination

Future Vision II Acquisition Corp., a Cayman Islands-based special purpose acquisition company (SPAC), has released a Form 8-K detailing the results of an extraordinary general meeting of shareholders held on July 23, 2026. The company’s securities trade on the Nasdaq Stock Market LLC under the symbols FVNNU (units), FVN (ordinary shares), and FVNNR (rights).

Key Points for Investors

  • Business Combination Approved: Shareholders approved the proposed Merger Agreement and the related transactions, marking a pivotal step in the SPAC’s lifecycle.
  • Voting Results: Of the 7,544,000 ordinary shares issued and outstanding as of the record date (June 15, 2026), 5,812,556 shares (approximately 80.6%) were present in person or represented by proxy, constituting a quorum.
  • Proposal 1 – Business Combination: The proposal received overwhelming support, with 5,688,865 votes in favor and zero abstentions. This indicates strong shareholder consensus for moving forward with the merger.
  • Redemption Opportunity: The filing references the redemption of ordinary shares, a typical event in SPAC transactions. Shareholders who do not wish to participate in the combined entity may redeem their shares for cash, which can impact the float and market dynamics.
  • Emerging Growth Company Status: The company is classified as an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards. This may affect future reporting and financial transparency.
  • No Written Communications, Soliciting Material, or Tender Offers: The report confirms no written communications pursuant to Securities Act Rule 425, no soliciting material under Exchange Act Rule 14a-12, and no pre-commencement tender offers under Rules 14d-2(b) or 13e-4(c). This means no additional disclosures or offers related to the merger are required at this time.
  • Amended and Restated Articles: The company’s Amended and Restated Memorandum and Articles of Association (effective September 11, 2024) are incorporated by reference, providing the current governance framework for the combined entity.

Details on Securities

Title of each class Trading Symbol(s) Name of each exchange on which registered
Units, each consisting of one Ordinary Share (par value \$0.0001/share) and one right to acquire 1/10th of an Ordinary Share FVNNU Nasdaq Stock Market LLC
Ordinary Shares included as part of the Units FVN Nasdaq Stock Market LLC
Rights included as part of the Units FVNNR Nasdaq Stock Market LLC

What Shareholders Need to Know

  • Business Combination Completion: The approval of the merger agreement is a milestone event for the SPAC, potentially leading to a transition from a shell company to an operating business. This can significantly affect the share price, especially as the details of the target company and its prospects become clearer.
  • Redemption Impact: Shareholder redemptions can reduce the public float and change the capital structure. If a large number of shares are redeemed, it may impact liquidity and the value of remaining shares.
  • Price Sensitivity: SPAC mergers are often price-sensitive events. Investors should monitor subsequent filings for details on the merged entity, financial projections, and management commentary, as these will drive future share performance.
  • Emerging Growth Company: This status may mean reduced disclosure requirements and exemptions from certain regulations, which can be attractive for growth but may reduce transparency.
  • No Additional Offers or Solicitation: There are no new tender offers or solicitation materials, indicating the merger process is proceeding as planned without regulatory complications.

Signatures

The filing was signed by Danhua Xu, on behalf of Future Vision II Acquisition Corp., dated July 27, 2026.

Conclusion

The approval of the business combination by shareholders is a significant, price-sensitive event for Future Vision II Acquisition Corp. Investors should watch for further announcements regarding the completion of the merger, potential redemptions, and new details about the post-merger entity. SPAC mergers can result in substantial changes to the share price due to shifts in business direction, capital structure, and investor sentiment.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review all official filings and consult with financial advisors before making investment decisions. The information presented is based on SEC filings as of July 23, 2026, and may be subject to change or update.




View Future Vision II Acquisition Corp. Historical chart here



Monopar Therapeutics Initiates FDA Rolling Submission for ALXN1840 (Tiomolibdate Choline) in Wilson Disease

Monopar Therapeutics Initiates Rolling NDA Submission for AL...

GE HealthCare Reports Strong Q2 2026 Results: Revenue Growth, Segment Performance, and Innovation Highlights

GE HealthCare Reports Q2 2026 Results: Key Highlights for In...

Financial Performance Highlights and Key Changes: Detailed Analysis of Year-Over-Year Results and Dollar Changes

Plumas Bancorp Reports Record Q2 2026 Earnings—Shareholder U...